
American BriVision Issues Shareholder Letter Outlining Achievements of 2020 and Outlook for 2021
FREMONT, CA, Jan. 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- American BriVision (Holding) Corporation (OTCQB: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, central nervous system (CNS), and …